维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Aggerbeck"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia显示文摘	Wetterau J R Aggerbeck L P Bouma M E	1992	Science1992，258，：	1
2	Double-blind randomized Phase I study comparing rdESAT-6 to tuberculin as skin test reagent in the diagnosis of tuberculosis infection 显示文摘	Arend SM Franken WP Aggerbeck H	2008	Tuberculosis2008，88，3：	1
3	Safety of ESAT-6 显示文摘	Aggerbeck H Madsen SM	2005	Tuberculosis ( Edinb)2005，86，5：	1
4	Optimizing spotting solutions for increased reproducibility of cDNA microarrays 显示文摘	Rickman D S Herbert C J Aggerbeck L P	2008	Nucleic Acids Research2008，31，18：	1
5	Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia显示文摘	Wetterau JR Aggerbeck LP Bouma ME	1992	Science1992，258，：	1
6	The role of the microsomal triglygeride transfer protein in abetalipoproteinemia显示文摘	Berriot-Varoqueaux N Aggerbeck LP Samson-Bouma M	2000	Annu Rev Nutr2000，20，：	1
7	Absence of microsomal triglyceride transfer protein in individuals With abetalipoproteinemia 显示文摘	Wetterau JR Aggerbeck LP Bouma ME	1992	Science1992，258，5084：	1
8	Influence of peritoneal factors on port - site metastases in a xenograft ovarian cancer model 显示文摘	Agostini A Robin F Aggerbeck M	2001	BJOG2001，108，8：	1
9	Influence of peritoneal factors on portsite metastases in a xenograft ovarian cancer model显示文摘	Robin F Aggerbeck M	2001	Br J Obstet Gynaecol2001，108，：	1
10	De- termination of interleukin-4-responsive region in the human cytochrome P450 2El gene promoter显示文摘	Abdel-Razzak Z Garlatti M Aggerbeck M	2004	Bio- chem Pharmacol2004，68，7：	1
11	Structural properties of the microsomal triglyceride-transfer protein eomplex显示文摘	Wetterau J R Aggerbeck L P Laplaud P M	1991	Biochemistry1991，30，18：	1
12	Apolipoprotein B48 Glycosylation in Abetalipoproteinemia and Anderson’s Disease显示文摘	Nathalie Berriot-Varoqueaux A.Hayssam Dannoura Alain Moreau Nicole Verthier Agnès Sassolas Guillaume Cadiot Alain Lachaux Anne Munck Jacques Schmitz Lawrence P. Aggerbeck Marie-Elisabeth Samson-Bouma	2001	Gastroenterology2001，，5：	1
13	Structural properties of the microsomal triglyceride-transfer protein complex显示文摘	Wetterau J R Aggerbeck L P Lapland P M	1991	Biochemistry1991，30，18：	1
14	Agard, Crystallization and preliminary X ray all{fraction studies on the amino terminal (receptor binding) domain of human apoli poprotein E3 from serum very low density lipoproteins显示文摘	Aggerbeck L P Wetterau J R Weisgraber K H	1988	Journal of molecular biology1988，202，17：	1
15	Cell-specific,promoter-dependent mineralocorticoid agonist activity of spironolactone显示文摘	MASSAAD C LOMBES M AGGERBECK M	1997	Mol Pharmacol1997，51，2：	1
16	Safety of ESAT-6 显示文摘	Aggerbeck H Madsen SM	2006	Tuberculosis ( Edinb)2006，86，5：	1
17	Double-blind randomized Phase I study comparing rdESAT-6 to tuberculin as skin test reagent in the diagnosis of tuberculosis infection 显示文摘	Arend SM Franken WP Aggerbeck H	2008	Tuberculosis (Edinb)2008，88，3：	1
18	PPARα regulates the hepatotoxic biomarker alanine aminotransferase (ALT1) gene expression in human hepatocytes显示文摘	Petra Thulin Ingalill Rafter Kenneth Stockling Celine Tomkiewicz Ensio Norjavaara Martine Aggerbeck Heike Hellmold Ewa Ehrenborg Ulf Andersson Ian Cotgreave Bj?rn Glinghammar	2008	Toxicology and Applied Pharmacology2008，，1：	1
19	Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia 显示文摘	Wetterau JR Aggerbeck LP Bouma ME	1992	Science1992，258，：	1
20	测定血清中白喉抗毒素含量的Vero细胞试验的改进显示文摘Vero细胞试验已经被应用在测定人血清中白喉抗毒素的保护力或者通过测定免疫小鼠血清中抗毒素滴度评价白喉类毒素的效力。白喉毒素能抑制培养物中Vero细胞的新陈代谢和存活,这种毒素效应可以被血清样品中的白喉抗毒素中和。在Vero细胞上,血清样品的滴度在有固定量的白喉毒素存在时被测出。	Aggerbeck H 白巍孙淑滨	1992	微生物学免疫学进展1992，20，3：	0

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示